Insomnia costing $42B a year; Minorities, poor less likely to see doctors with EMRs;

> A new report from Sanofi-Aventis and The Center for Medicine in the Public Interest contends that delays in insomnia diagnosis and treatment is costing the U.S. at least $42 billion in direct and indirect healthcare costs per year. Article [1]

> Minorities and the poor are less likely to see doctors who have an electronic medical records system in place, a new study suggests. FierceEMR [2]

> Forest Laboratories had hoped that Celexa would prove to be helpful in cutting down on autistic kids' repetitive behaviors, but sadly for them, a new trial at NIH suggests that it does not. FiercePharma [3]

> Given its prevalence, you won't be surprised to hear that the iPhone is becoming a major battleground for pharmaceutical companies, who see it as a major platform for direct-to-consumer marketing. FierceMobileHealthcare [4]

And Finally... When it came to the battle of the eating titans, Japan captured the flag. Article [5]